首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
【2h】

Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)

机译:芳基烃受体(AHR)配体作为选择性AHR调节剂(SAHRMS)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aryl hydrocarbon receptor (AhR) was first identified as the intracellular protein that bound and mediated the toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) and dioxin-like compounds (DLCs). Subsequent studies show that the AhR plays an important role in maintaining cellular homeostasis and in pathophysiology, and there is increasing evidence that the AhR is an important drug target. The AhR binds structurally diverse compounds, including pharmaceuticals, phytochemicals and endogenous biochemicals, some of which may serve as endogenous ligands. Classification of DLCs and non-DLCs based on their persistence (metabolism), toxicities, binding to wild-type/mutant AhR and structural similarities have been reported. This review provides data suggesting that ligands for the AhR are selective AhR modulators (SAhRMs) that exhibit tissue/cell-specific AhR agonist and antagonist activities, and that their functional diversity is similar to selective receptor modulators that target steroid hormone and other nuclear receptors.
机译:首先将芳基烃受体(AHR)鉴定为细胞内蛋白,其结合并介导2,3,7,8-四氯二氯胺-P-二恶蛋白(TCDD,DIOXIN)和二恶英样化合物(DLC)的毒性作用。随后的研究表明,AHR在维持细胞稳态和病理生理学方面发挥着重要作用,并且越来越多的证据表明AHR是一个重要的药物目标。 AHR结合结构多样化的化合物,包括药物,植物化学和内源性生化,其中一些可以用作内源性配体。已经报道了DLCS和非DLC的分类,基于它们的持久性(新陈代谢),毒性,与野生型/突变AHR和结构相似度的结合。该综述提供了数据,表明AHR的配体是具有表现出组织/细胞特异性AHR激动剂和拮抗剂活性的选择性AHR调节剂(SAHRMS),并且它们的功能多样性类似于靶向类固醇激素和其他核受体的选择性受体调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号